Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. The compounds of the subject invention may exhibit potent activities against bacteria, including gram positive organisms, and may be useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. The compounds of the subject invention may exhibit potent activities against bacteria, including Gram positive organisms, and may be useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
Bore G. Raju - Fremont CA, US Hardwin O'Dowd - Hayward CA, US Hongwu Gao - Union City CA, US Dinesh V. Patel - Fremont CA, US Jaoquim Trias - Millbrae CA, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 31/397 C07D 205/00
US Classification:
51421017, 548950
Abstract:
Novel N-hydroxyamide derivatives are disclosed. These N-hydroxyamide derivatives inhibit UPD-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria and are therefore useful as antimicrobials and antibiotics. Methods of synthesis and of use of the compounds are also disclosed.
Isoindolinone Inhibitors Of Phosphatidylinositol 3-Kinase
Alex Aronov - Newton MA, US Jon H. Come - Cambridge MA, US Robert J. Davies - Arlington MA, US Albert Charles Pierce - Cambridge MA, US Philip N. Collier - Cambridge MA, US Hardwin O'Dowd - Boston MA, US James A. Henderson - Cambridge MA, US Elaine B. Krueger - Milton MA, US Arnaud Le Tiran - Crossy sur Seine, FR Yusheng Liao - Lexington MA, US David Messersmith - Somerville MA, US Jian Wang - Newton MA, US Suganthini S. Nanthakumar - Newton MA, US Jingrong Cao - Newton MA, US Upul Keerthi Bandarage - Lexington MA, US Anne-Laure Grillot - Milton MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
The present invention relates to compounds useful as inhibitors of PI3K, particularly of PI3Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Arnaud Le Tiran - Croissy sur Seine, FR Anne-Laure Grillot - Milton MA, US Paul S. Charifson - Framingham MA, US Yousef Laafiret Bennani - Lorraine, CA Hardwin O'Dowd - Boston MA, US Emanuele Perola - Brookline MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A01N 43/54 C07D 239/42 C07D 471/04
US Classification:
514256, 544333
Abstract:
The present invention relates to a compound of formula (I).
Jason G. Lewis - Castro Valley CA, US Sampath K Anandan - Fremont CA, US Hardwin O'Dowd - Hayward CA, US Mikhail F Gordeev - Castro Valley CA, US Liansheng Li - San Diego CA, US
Assignee:
Pfizer Inc - New York NY
International Classification:
C07H 15/16
US Classification:
536 163, 536 162, 536 165
Abstract:
Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. The compounds of the subject invention may exhibit potent activities against bacteria, including Gram positive organisms, and may be useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
Bore Raju - Fremont CA, US Romeo Ciabatti - Novate Milanese, IT Sonia Maffioli - Milano, IT Upinder Singh - Fremont CA, US Gabriella Romano - Legnano, IT Elena Michelucci - Legnano, IT Paolo Tiseni - Milano, IT Gianpaolo Candiani - Gorgonzola, IT Bum Kim - Union City CA, US Hardwin O'Dowd - Hayward CA, US
Assignee:
VICURON PHARMACEUTICALS INC. - King of Prussia PA
International Classification:
A61K 38/14 C07K 9/00 C07K 7/64 A61K 38/12
US Classification:
514008000, 514009000, 530317000
Abstract:
Novel ramoplanin derivatives are disclosed. These ramoplanin derivatives exhibit antibacterial activity. As the compounds of the subject invention exhibit potent activities against gram positive bacteria, they are useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
Isoindolinone Inhibitors Of Phosphatidylinositol 3-Kinase
Alex Aronov - Newton MA, US Jon H. Come - Cambridge MA, US Robert J. Davies - Watertown MA, US Albert Charles Pierce - Cambridge MA, US Philip N. Collier - Cambridge MA, US Hardwin O'Dowd - Boston MA, US James A. Henderson - Cambridge MA, US Elaine B. Krueger - Milton MA, US Arnaud Le Tiran - Croissy sur Seine, FR Yusheng Liao - Lexington MA, US David Messersmith - Somerville MA, US Jian Wang - Newton MA, US Suganthini S. Nanthakumar - Newton MA, US Jingrong Cao - Newton MA, US Upul Keerthi Bandarage - Lexington MA, US Anne-Laure Grillot - Somerville MA, US
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED - Cambridge MA
The present invention relates to compounds useful as inhibitors of PI3K, particularly of PI3Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Lc Ms Organic Synthesis Medicinal Chemistry Organic Chemistry Hplc Chromatography Drug Discovery Lead Change Drug Design Nmr Small Molecules Medicine Purification Biotechnology Chemistry Drug Development Pharmaceutical Industry Synthetic Organic Chemistry